F FANAPT ILOPERIDONE TABLETS
Live / Registered — Registered and renewed (as of 13 Dec 2019)
What this means for you
Registered since 08 Jun 2010. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Jun 2020).
Record
- Serial number
- 77694574
- Registration number
- 3800662
- Mark type
- Design + words
- Filed
- 19 Mar 2009
- Published for opposition
- 07 Jul 2009
- Registered
- 08 Jun 2010
- Next maintenance due
- 08 Jun 2020
- Attorney of record
- Jayme M. Torelli
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in the treatment of the central nervous system
Owner
- Vanda Pharmaceuticals Inc., Washington, DC, US
- Vanda Pharmaceuticals Inc., Rockville, MD, US
- Vanda Pharmaceuticals Inc., Rockville, MD, US
Prosecution history
- 13 Dec 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 13 Dec 2019 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 13 Dec 2019 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 13 Dec 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Oct 2019 — TEAS SECTION 8 & 9 RECEIVED
- 08 Jun 2019 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 10 Jun 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 10 Jun 2016 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 10 Jun 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 31 Mar 2016 — TEAS SECTION 8 & 15 RECEIVED
- 08 Jun 2010 — REGISTERED-PRINCIPAL REGISTER
- 04 May 2010 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
- 03 May 2010 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 03 May 2010 — ASSIGNED TO LIE
- 22 Apr 2010 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED